Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05408533 · ClinicalTrials.gov registry record · NA
Silver-Coated vs Standard Catheter for UTI Prevention
A NA study, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT05408533: Completed NA study, sponsored by TriHealth.
NCT05408533 is a NA study that has completed, run by TriHealth. The registered enrollment target is 310 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05408533, a NA study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
Primary Aim: To determine whether silver-coated transurethral catheter decreases the incidence of culture-confirmed urinary tract infection for women with catheter-managed urinary retention after pelvic reconstructive surgery Secondary Aims: To assess difference in bacterial uropathogens isolated in urine cultures Adverse symptoms possibly caused by silver-coated catheter
Primary Outcome
Post-operative UTI rate
Interventions
- DEVICE 2-Way Foley Urethral Urinary Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2022-06-14 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
What the finished NCT05408533 record still lists
NCT05408533 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which 2-Way Foley Urethral Urinary Catheter is the first listed.
NCT05408533 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05408533 about?
NCT05408533 is a clinical study titled "Silver-Coated vs Standard Catheter for UTI Prevention". Primary Aim: To determine whether silver-coated transurethral catheter decreases the incidence of culture-confirmed urinary tract infection for women with catheter-managed urinary retention after pelvic reconstructive surgery Secondary Aims: To assess difference in bacterial uropathogens isolated ...
What is the current status of trial NCT05408533?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2022-06-14. Estimated completion is 2024-05-01.
What interventions are being tested in trial NCT05408533?
The interventions under investigation include: 2-Way Foley Urethral Urinary Catheter (DEVICE).
Who is sponsoring clinical trial NCT05408533?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05408533's enrollment target sits among peer trials
310 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI